AI Article Synopsis

  • Spinal anesthesia has benefits, but reducing the local anesthetic dose can lead to side effects; using adjuvants like ketamine and tramadol can enhance pain relief while minimizing these issues.
  • The study aimed to assess how well ketamine and tramadol, when added to bupivacaine, improve spinal analgesia in terms of duration and safety, with a focus on factors like heart rate and side effects.
  • Results indicated that tramadol significantly prolonged spinal analgesia compared to bupivacaine alone, while ketamine also had a positive effect, suggesting both adjuvants could improve anesthesia outcomes.

Article Abstract

Background: Spinal anesthesia offers numerous advantages and desirable features. However, it is associated with various side effects related to local anesthetic agents used. Reducing the dose of local anesthetic in spinal anesthesia can help minimize side effects but may lead to a diminished analgesic effect or failure of anesthesia. Therefore, adding an adjuvant may enhance the benefits while mitigating side effects.

Objective: This study aimed to evaluate the effects of ketamine and tramadol as adjuvants to bupivacaine on the duration of spinal analgesia. The objectives were to compare the three groups and prove their analgesic effects, safety, and superiority. The primary outcomes were the duration of spinal analgesia, as well as the onset and duration of both sensory and motor blocks. Secondary outcomes included the heart rate, mean arterial pressure, and the incidence of undesired effects such as nausea, vomiting, sedation, shivering, and postoperative headache.

Methods: In this double-blind randomized controlled trial, 120 female patients undergoing elective open unilateral ovarian cystectomy under spinal anesthesia were studied. The inclusion criteria included patients aged 16-45 years with a physical status classified as American Society of Anesthesiologists (ASA) class I and II. Patients were randomly allocated into three groups: group B (n=40) received only bupivacaine, group BK (n=40) received bupivacaine mixed with preservative-free ketamine, and group BT (n=40) received bupivacaine mixed with preservative-free tramadol.

Results: The mean duration of spinal analgesia, measured in minutes, showed significant differences (P < 0.001) between group BK (165 ± 4) and group B (170 ± 5). There was also a significant difference between group BT (313 ± 8) and group B (170 ± 5) (P < 0.001). Additionally, significant differences were observed between group BK (165 ± 4) and group BT (313 ± 8) (P < 0.001).

Conclusion: The administration of 25 mg of ketamine and 25 mg of tramadol as adjuvants to bupivacaine in spinal anesthesia significantly affected the postoperative duration of analgesia. Tramadol prolonged the duration of spinal anesthesia, while ketamine shortened it. The use of both adjuvants did not result in undesired effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10890904PMC
http://dx.doi.org/10.7759/cureus.54776DOI Listing

Publication Analysis

Top Keywords

spinal anesthesia
24
duration spinal
16
ketamine tramadol
12
tramadol adjuvants
12
adjuvants bupivacaine
12
spinal analgesia
12
group n=40
12
n=40 received
12
received bupivacaine
12
spinal
9

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!